主要学习及工作经历 1997.9-2002.7 四川大学华西医学中心法医学专业 本科生 2002.9-2007.1 北京大学医学部 细胞生物学专业 硕博连读生 2007.8-今 北京大学医学部 细胞生物学专业 讲师、副教授

研究方向 肿瘤细胞生物学

基金来源 国家自然科学基金

代表论文 1. Yang H, Lin M, Xiong FX,Yang Y, Nie X, McNutt MA, Zhou RL. Combined Lysosomal Protein Transmembrane 4 Beta-35 and Argininosuccinate Synthetase Expression Predicts Clinical Outcome in Hepatocellular Carcinoma Patients. Surgery Today 2011 in Press 2. Yang H, Xiong F, Wei X, Yang Y, McNutt MA, Zhou R. Overexpression of LAPTM4B-35 promotes growth and metastasis of hepatocellular carcinoma in vitro and in vivo. Cancer Lett. 2010 Aug 28;294(2):236-44. Epub 2010 Mar 3. 3. Yang H, Xiong F, Qi R, Liu Z, Lin M, Rui J, Su J, Zhou R. LAPTM4B-35 is a novel prognostic factor of hepatocellular carcinoma.J Surg Oncol. 2010 Apr 1;101(5):363-9. 4. Yang H, Xiong FX, Lin M, Yang Y, Nie X, Zhou RL. LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma. J Cancer Res Clin Oncol. 2010 Feb;136(2):275-81. Epub 2009 Aug 19. 5. Yang H, Lin M, Xiong FX,Yang Y, Nie X, Zhou RL.Reduced expression of ASS is closely related to clinicopathological features and post-resectional survival of hepatocellular carcinoma. Oncol Lett, 2010 Jan;1(1):31-36 6. Li L, Wei XH, Pan YP, Li HC, Yang H, He QH, Pang Y, Shan Y, Xiong FX, Shao GZ, Zhou RL. LAPTM4B: a novel cancer-associated gene motivates multidrug resistance through efflux and activating PI3K/AKT signaling.Oncogene. 2010 Oct 28;29(43):5785-95. 7. Meng FL, Yin MZ, Song HT, Yang H, Lou G, Zhou RL. LAPTM4B-35 overexpression is an independent prognostic marker in endometrial carcinoma. Int J Gynecol Cancer. 2010 Jul;20(5):745-50. 8. Zhou L, He XD, Yu JC, Zhou RL, Yang H, Qu Q, Rui JA. Overexpression of LAPTM4B promotes growth of gallbladder carcinoma cells in vitro. Am J Surg. 2010 Apr;199(4):515-21. Epub 2009 Dec 2. 9. Liu X, Xiong F, Wei X, Yang H, Zhou R. LAPTM4B-35, a novel tetratransmembrane protein and its PPRP motif play critical roles in proliferation and metastatic potential of hepatocellular carcinoma cells.Cancer Sci. 2009 Dec;100(12):2335-40. Epub 2009 Sep 4. 10. Yang Y, Yang H, McNutt MA, Xiong F, Nie X, Li L, Zhou R. LAPTM4B overexpression is an independent prognostic marker in ovarian carcinoma. Oncol Rep. 2008 Nov;20(5):1077-83.